We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+6.15%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.67B
AUM Growth
-$188M
Cap. Flow
-$254M
Cap. Flow %
-15.17%
Top 10 Hldgs %
4.56%
Holding
2,166
New
434
Increased
531
Reduced
725
Closed
452

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$17.8M
2
NKE icon
Nike
NKE
+$17.7M
3
COTY icon
Coty
COTY
+$12.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$10.2M
5
GXP
Great Plains Energy Incorporated
GXP
+$9.61M

Sector Composition

Rank Sector Weight
1 Industrials 14.76%
2 Consumer Discretionary 14.49%
3 Healthcare 12.49%
4 Financials 12.28%
5 Technology 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLG
2001
Flagstar Bank National Association
FLG
$5.94B
-4,974
Closed -$212K
XIFR
2002
XPLR Infrastructure LP
XIFR
$1.12B
-20,700
Closed -$579K
TVRD
2003
Tvardi Therapeutics
TVRD
$19M
-1,089
Closed -$327K
BECN
2004
DELISTED
Beacon Roofing Supply, Inc.
BECN
-8,679
Closed -$365K
ITCI
2005
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-14,100
Closed -$215K
VOXX
2006
DELISTED
VOXX International Corporation Class A
VOXX
-66,431
Closed -$199K
ROIC
2007
DELISTED
Retail Opportunity Investments Corp.
ROIC
-14,191
Closed -$312K
VGR
2008
DELISTED
Vector Group Ltd.
VGR
-57,088
Closed -$753K
SLCA
2009
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-4,538
Closed -$211K
WRK
2010
DELISTED
WestRock Company
WRK
-7,180
Closed -$348K
TRVN
2011
DELISTED
Trevena, Inc.
TRVN
-56
Closed -$236K
SPLK
2012
DELISTED
Splunk Inc
SPLK
-6,504
Closed -$382K
BFX
2013
DELISTED
BowFlex Inc.
BFX
-43,903
Closed -$997K
MRTX
2014
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-34,999
Closed -$231K
SGEN
2015
DELISTED
Seagen Inc. Common Stock
SGEN
-3,877
Closed -$209K
CCF
2016
DELISTED
Chase Corporation
CCF
-3,643
Closed -$252K
ACGN
2017
DELISTED
Aceragen Inc
ACGN
-519
Closed -$180K
KDNY
2018
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-3,800
Closed -$236K
ACOR
2019
DELISTED
Acorda Therapeutics
ACOR
-185
Closed -$463K
LCI
2020
DELISTED
Lannett Company, Inc.
LCI
-5,537
Closed -$588K
VIVO
2021
DELISTED
Meridian Bioscience Inc
VIVO
-66,132
Closed -$1.28M
OTIC
2022
DELISTED
Otonomy, Inc.
OTIC
-16,642
Closed -$303K
CFMS
2023
DELISTED
Conformis, Inc. Common Stock
CFMS
-1,360
Closed -$337K
FNHC
2024
DELISTED
FedNat Holding Company Common Stock
FNHC
-13,262
Closed -$248K
MANT
2025
DELISTED
Mantech International Corp
MANT
-19,031
Closed -$717K

Similar funds

GSA Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, GSA Capital Partners held 2,166 positions worth $1.67B, down 10% from $1.86B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

GSA Capital Partners withdrew a net $254M in Q4 2016, closing 452 positions and reducing 725 holdings. Its most notable exit was Nike, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, GSA Capital Partners opened a new position in S&P Global worth $12.5M.

  • GSA Capital Partners's largest Q4 2016 buy was S&P Global: 116,681 shares worth $12.5M.
  • GSA Capital Partners added most to Meta Platforms (Facebook) in Q4 2016, an estimated $8.01M increase.
  • GSA Capital Partners's biggest Q4 2016 reduction was Wells Fargo, cutting an estimated $17.8M.
  • GSA Capital Partners fully exited Nike in Q4 2016, selling an estimated $17.7M.
  • GSA Capital Partners's ten largest holdings make up 4.6% of its $1.67B portfolio in Q4 2016.
  • GSA Capital Partners opened 434 new positions and closed 452 in Q4 2016.
  • GSA Capital Partners's portfolio value fell 10% quarter-over-quarter to $1.67B.

Based on GSA Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.